Fundraising Fox
Silverback Therapeutics
AcquiredSeattle, US · Founded 2016 · Delaware corporation · 205 employees on LinkedIn · 7 known investors
Find your way into Silverback Therapeutics
Sign up to see every warm intro you have to Silverback Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Silverback Therapeutics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
PA
Investors · 7
Pontifax Venture Capitallisted by Pontifax Venture CapitalHerzeliya
How we know: Pontifax Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us
US Venture Partnerslisted by US Venture PartnersMenlo Park · $500K – $10M
How we know: US Venture Partners's portfolio page · Not right? Tell us
AlexandriareportedPasadena
How we know: press coverage · Not right? Tell us
Nextech InvestreportedZurich · $648K – $3.2M
How we know: a partner's Signal profile · Not right? Tell us
OrbiMedreportedNew York · $1M – $75M
How we know: press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$139.3M disclosed across 6 of 7 rounds · 2016–2020
▶$85MraisedOct 2020 · 31 investors · BiotechnologyRule 506(b)
▶$85MraisedOct 2020 · 31 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan RootDirector
- Thilo SchroederDirector
- Scott PlatshonDirector
- Laura ShawverExecutive Officer, Director
- Vickie L. CappsDirector
- Robert HershbergDirector
- Saqib IslamDirector
- Peter A. ThompsonDirector
- Offering amount
- $85M
- Amount sold
- $85M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$31.8MraisedMar 2020 · 16 investors · BiotechnologyRule 506(b)
▶$31.8MraisedMar 2020 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter ThompsonExecutive Officer, Director
- Robert HershbergDirector
- Thilo SchroederDirector
- Jonathan RootDirector
- Saqib IslamDirector
- Offering amount
- $78.7M
- Amount sold
- $31.8M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$12.5MraisedSep 2018 · 3 investors · Other TechnologyRule 506(b)
▶$12.5MraisedSep 2018 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Peter A. ThompsonExecutive Officer, Director
- Robert HershbergDirector
- Saqib IslamDirector
- Offering amount
- $20M
- Amount sold
- $12.5M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$3.7KraisedJan 2018 · 1 investors · BiotechnologyRule 506(b)
▶$3.7KraisedJan 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Saqib IslamDirector
- Robert HershbergDirector
- Peter A. ThompsonExecutive Officer, Director
- Offering amount
- $3.7K
- Amount sold
- $3.7K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$10MraisedFeb 2017 · 1 investors · BiotechnologyRule 506(b)
▶$10MraisedFeb 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter A. ThompsonExecutive Officer, Director
- Offering amount
- $60M
- Amount sold
- $10M
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$25KofferedNov 2016 · BiotechnologyRule 506(b)
▶$25KofferedNov 2016 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter A. ThompsonExecutive Officer, Director
- Offering amount
- $25K
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$200raisedApr 2016 · 2 investors · BiotechnologyRule 506(b)
▶$200raisedApr 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter A. ThompsonExecutive Officer, Director
- Offering amount
- $200
- Amount sold
- $200
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Silverback Therapeutics went on to found or lead other companies.
In the news
Frequently asked questions
- Who are Silverback Therapeutics's investors?
- Silverback Therapeutics's investors include EcoR1 Capital, Pontifax Venture Capital, RA Capital, US Venture Partners, Alexandria, Nextech Invest, OrbiMed.
- How much funding has Silverback Therapeutics raised?
- Silverback Therapeutics has disclosed $139.3M raised across 6 of its 7 known rounds.
- Where is Silverback Therapeutics headquartered?
- Silverback Therapeutics is headquartered in Seattle, US.